Feasibility Assessment of a Biomarker-Guided Kidney-Sparing Sepsis Bundle: The Limiting Acute Kidney Injury Progression In Sepsis Trial

OBJECTIVES:. To determine the feasibility, safety, and efficacy of a biomarker-guided implementation of a kidney-sparing sepsis bundle (KSSB) of care in comparison with standard of care (SOC) on clinical outcomes in patients with sepsis. DESIGN:. Adaptive, multicenter, randomized clinical trial. SET...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Hernando Gómez, MD, Alexander Zarbock, MD, Stephen M. Pastores, MD, Gyorgy Frendl, MD, Sven Bercker, MD, Pierre Asfar, MD, Steven A. Conrad, MD, Jaques Creteur, MD, James Miner, MD, Jean Paul Mira, MD, Johan Motsch, MD, Jean-Pierre Quenot, MD, Thomas Rimmelé, MD, Peter Rosenberger, MD, Christophe Vinsonneau, MD, Bob Birch, PhD, Fabienne Heskia, MS, Julien Textoris, MD, Luca Molinari, MD, Louis M. Guzzi, MD, Claudio Ronco, MD, John A. Kellum, MD
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Wolters Kluwer 2023-08-01
Seri Bilgileri:	Critical Care Explorations
Online Erişim:	http://journals.lww.com/10.1097/CCE.0000000000000961
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Feasibility Assessment of a Biomarker-Guided Kidney-Sparing Sepsis Bundle: The Limiting Acute Kidney Injury Progression In Sepsis Trial

Benzer Materyaller